Citation Impact
Citing Papers
Factors associated with spontaneous clearance of chronic hepatitis C virus infection
2016
HIV Type 1 Isolates from 200 Untreated Individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large Predominance of CRF01_AE and Presence of Major Resistance Mutations to Antiretroviral Drugs
2003 StandoutNobel
HIV Type 1 Diversity in France, 1999–2001: Molecular Characterization of non-B HIV Type 1 Subtypes and Potential Impact on Susceptibility to Antiretroviral Drugs
2003
Acute Hepatitis C Virus in an HIV Clinic: A Screening Strategy, Risk Factors, and Perception of Risk
2011
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic–androgenic steroid injectors in Victoria, Australia
2002
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility
2010
Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups
2018
Molecular Phylodynamics of the Heterosexual HIV Epidemic in the United Kingdom
2009
Ethical issues posed by cluster randomized trials in health research
2011
Injecting risk behaviour and related harm among men who use performance‐ and image‐enhancing drugs
2008
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Anabolic Androgenic Steroids
2006 Standout
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Burden of liver diseases in the world
2018 Standout
Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention
2014
Hepatitis C: The next 25 years
2014 StandoutNobel
The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM)
2015
Promotion of smoking cessation in developing countries: a framework for urgent public health interventions
2004
Impact of COVID-19 pandemic on mental health in the general population: A systematic review
2020 Standout
Consort 2010 statement: extension to cluster randomised trials
2012 Standout
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
The changing epidemiology of hepatitis C virus infection in Europe
2007
Direct-acting antiviral agents for HCV infection affecting people who inject drugs
2017
Impact of harm reduction practice on the use of non-prescribed performance and image-enhancing drugs (PIEDs): The PUSH! Audit
2023 StandoutNobel
Can hepatitis C virus infection be eradicated in people who inject drugs?
2014
Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study
2017
Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection: The Influence of Time and Place
2008
Best Practices for Developing and Validating Scales for Health, Social, and Behavioral Research: A Primer
2018 Standout
Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit
2008
A framework for assessing health system resilience in an economic crisis: Ireland as a test case
2013
Dried Blood Spot for Hepatitis C Virus Serology and Molecular Testing
2009
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships
2017
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013
2016
Use of anabolic steroids and associated health risks among gay men attending London gyms
2002
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
2008 Standout
HIV risk behaviours among gay men who use anabolic steroids
1999
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs
2019 StandoutNobel
Health Care Engagement Behaviors of Men who use Performance- and Image-Enhancing Drugs in Australia
2019
Sexual transmission of hepatitis C virus among gay and bisexual men: a systematic review
2016
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States
2007
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
2017
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Long-Term Use of Bisphosphonates in Osteoporosis
2010
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation
2007
Development of a multiplex phenotypic cell-based high throughput screening assay to identify novel hepatitis C virus antivirals
2013 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
A review of definitions and measures of system resilience
2015 Standout
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis
2017
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
2017
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
2014 StandoutNobel
The global economic crisis: effects on mental health and what can be done
2013
The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs
2014
Works of Jane Parry being referenced
Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis
2005
The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales
1998
Improvingblood‐borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service
2008
Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size
2009
Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics
2008
National Surveillance of HIV-1 Subtypes for England and Wales
2001
A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection
2003
Diagnosis of acute hepatitis C virus infection and estimated incidence in low‐ and high‐risk English populations
2008
Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial
2008
Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking
2014
China makes its first antiretroviral drugs for treating AIDS
2002
Doctors hope consensus on brain death in China will boost transplants
2008
Health amid a financial crisis: a complex diagnosis
2009
Hepatitis C in men who have sex with men in L ondon – a community survey
2013